Pharmacokinetics of high dose melphalan
暂无分享,去创建一个
W. Knight | T. Ludden | J. Kuhn | M. Hersh | Marla R. Hersh | Thomas M. Ludden | William A. III Knight
[1] A. G. Bosanquet,et al. Pharmacokinetics of oral and intravenous melphalan during routine treatment of multiple myeloma. , 1982, European journal of cancer & clinical oncology.
[2] R. Makuch,et al. Association between human tumor colony-forming assay results and response of an individual patient's tumor to chemotherapy. , 1981, The American journal of medicine.
[3] T. L. Evans,et al. Kinetics of intravenous melphalan , 1979, Clinical pharmacology and therapeutics.
[4] D. Hedley,et al. Marrow autotransplantation accelerates haematological recovery in patients with malignant melanoma treated with high-dose melphalan. , 1979, British Journal of Cancer.
[5] A. Belch,et al. Pharmacology of intravenous melphalan in patients with multiple myeloma. , 1979, Cancer treatment reviews.
[6] D. Alberts,et al. High-pressure liquid chromatographic analysis of melphalan in plasma. , 1978, Journal of pharmaceutical sciences.
[7] M. Tattersall,et al. Pharmaco-kinetics of melphalan following oral or intravenous administration in patients with malignant disease. , 1978, European journal of cancer.
[8] W. R. Bruce,et al. Comparison of the Sensitivity of Normal Hematopoietic and Transplanted Lymphoma Colony-Forming Cells to Chemotherapeutic Agents Administered In Vivo , 1966 .